drugset / Trial / NCT07659184
IRONCARE: Iron Treatment in Older Patients With Hip Fractures
Phase 4
Not yet recruiting
528 enrolled
University of Aarhus
Aarhus University Hospital · collabGødstrup Hospital · collabRanders Regional Hospital · collabRegion MidtJylland Denmark · collabRegionshospitalet Horsens · collabViborg Regional Hospital · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of this study is to investigate the effects of intravenous (IV) iron therapy compared to alternate-day oral iron treatment and no supplementation in older patients with hip fractures. This study will examine the impact of iron treatment on fatigue, functional decline, fear of falling, cognitive impairment, and quality of life, as well as its effects on iron stores and hemoglobin levels, with the overall goal of improving postoperative rehabilitation. The trial will be conducted on five different hospitals in the Central Region of Denmark (Region Midtjylland).
Timeline
- Start
- 2026-10-01
- Primary completion
- 2028-09-30
- Completion
- 2028-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ferric Derisomaltose | Unknown | — | Intravenous |
| Comparator | Ferrous Sulfate | Diagnostic / imaging agent | — | Oral |